Pfm Health Sciences, LP Opti Nose, Inc. Transaction History

Pfm Health Sciences, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$18.75 - $28.46 $6.27 Million - $9.51 Million	-334,297 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$15.91 - $20.82 $180,896 - $236,723	11,370 Added 3.52%	334,297 $6.69 Million
Q4 2017 Feb 14, 2018	BUY	$15.2 - $20.76 $4.91 Million - $6.7 Million	322,927	322,927 $6.1 Million

52.9M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $500M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.